Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 177

1.

A controlled trial comparing vidarabine with acyclovir in neonatal herpes simplex virus infection. Infectious Diseases Collaborative Antiviral Study Group.

Whitley R, Arvin A, Prober C, Burchett S, Corey L, Powell D, Plotkin S, Starr S, Alford C, Connor J, et al.

N Engl J Med. 1991 Feb 14;324(7):444-9.

2.

Predictors of morbidity and mortality in neonates with herpes simplex virus infections. The National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group.

Whitley R, Arvin A, Prober C, Corey L, Burchett S, Plotkin S, Starr S, Jacobs R, Powell D, Nahmias A, et al.

N Engl J Med. 1991 Feb 14;324(7):450-4.

3.

Antiviral agents for treatment of herpes simplex virus infection in neonates.

Jones CA, Walker KS, Badawi N.

Cochrane Database Syst Rev. 2009 Jul 8;(3):CD004206. doi: 10.1002/14651858.CD004206.pub2. Review.

PMID:
19588350
4.

Safety and efficacy of high-dose intravenous acyclovir in the management of neonatal herpes simplex virus infections.

Kimberlin DW, Lin CY, Jacobs RF, Powell DA, Corey L, Gruber WC, Rathore M, Bradley JS, Diaz PS, Kumar M, Arvin AM, Gutierrez K, Shelton M, Weiner LB, Sleasman JW, de Sierra TM, Weller S, Soong SJ, Kiell J, Lakeman FD, Whitley RJ; National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group..

Pediatrics. 2001 Aug;108(2):230-8.

PMID:
11483782
5.

Vidarabine versus acyclovir therapy in herpes simplex encephalitis.

Whitley RJ, Alford CA, Hirsch MS, Schooley RT, Luby JP, Aoki FY, Hanley D, Nahmias AJ, Soong SJ.

N Engl J Med. 1986 Jan 16;314(3):144-9.

PMID:
3001520
6.

Herpes simplex virus infections of the central nervous system. A review.

Whitley RJ.

Am J Med. 1988 Aug 29;85(2A):61-7. Review.

PMID:
3044095
7.
8.

Neonatal herpes simplex virus infections: pathogenesis and therapy.

Whitley RJ.

Pathol Biol (Paris). 1992 Sep;40(7):729-34. Review.

PMID:
1336158
9.

Acyclovir versus vidarabine in herpes simplex encephalitis.

Sk├Âldenberg B, Forsgren M.

Scand J Infect Dis Suppl. 1985;47:89-96.

PMID:
3912977
10.

Management of neonatal herpes simplex virus infection.

Kesson AM.

Paediatr Drugs. 2001;3(2):81-90. Review.

PMID:
11269641
11.

Neonatal herpes simplex virus infections. Presentation and management.

Whitley RJ.

J Reprod Med. 1986 May;31(5 Suppl):426-32.

PMID:
3522894
12.

Therapeutic challenges of neonatal herpes simplex virus infection.

Whitley RJ, Nahmias AJ.

Scand J Infect Dis Suppl. 1985;47:97-106.

PMID:
3868027
13.

A controlled trial comparing foscarnet with vidarabine for acyclovir-resistant mucocutaneous herpes simplex in the acquired immunodeficiency syndrome. The AIDS Clinical Trials Group.

Safrin S, Crumpacker C, Chatis P, Davis R, Hafner R, Rush J, Kessler HA, Landry B, Mills J.

N Engl J Med. 1991 Aug 22;325(8):551-5.

14.

Natural history of neonatal herpes simplex virus infections in the acyclovir era.

Kimberlin DW, Lin CY, Jacobs RF, Powell DA, Frenkel LM, Gruber WC, Rathore M, Bradley JS, Diaz PS, Kumar M, Arvin AM, Gutierrez K, Shelton M, Weiner LB, Sleasman JW, de Sierra TM, Soong SJ, Kiell J, Lakeman FD, Whitley RJ; National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group..

Pediatrics. 2001 Aug;108(2):223-9.

PMID:
11483781
15.

Factors indicative of outcome in a comparative trial of acyclovir and vidarabine for biopsy-proven herpes simplex encephalitis.

Whitley RJ, Alford CA, Hirsch MS, Schooley RT, Luby JP, Aoki FY, Hanley D, Nahmias AJ, Soong SJ.

Infection. 1987;15 Suppl 1:S3-8.

PMID:
3298070
16.

Neonatal herpes simplex virus infections.

Whitley RJ.

J Med Virol. 1993;Suppl 1:13-21. Review.

PMID:
8245879
17.

Neonatal herpes simplex virus infections.

Jacobs RF.

Semin Perinatol. 1998 Feb;22(1):64-71. Review.

PMID:
9523400
18.

Vidarabine therapy of neonatal herpes simplex virus infection.

Whitley RJ, Nahmias AJ, Soong SJ, Galasso GG, Fleming CL, Alford CA.

Pediatrics. 1980 Oct;66(4):495-501.

PMID:
7001331
19.

Administration of oral acyclovir suppressive therapy after neonatal herpes simplex virus disease limited to the skin, eyes and mouth: results of a phase I/II trial.

Kimberlin D, Powell D, Gruber W, Diaz P, Arvin A, Kumar M, Jacobs R, Van Dyke R, Burchett S, Soong SJ, Lakeman A, Whitley R.

Pediatr Infect Dis J. 1996 Mar;15(3):247-54.

PMID:
8852914
20.

Neonatal herpes simplex virus infection: follow-up evaluation of vidarabine therapy.

Whitley RJ, Yeager A, Kartus P, Bryson Y, Connor JD, Alford CA, Nahmias A, Soong SJ.

Pediatrics. 1983 Dec;72(6):778-85.

PMID:
6359047

Supplemental Content

Support Center